The insider sales are routine liquidity events tied to option exercises and do not signal a bearish view given the trivial proportion of market cap. Monitor for any material news (pipeline data, regulatory updates) that could explain the timing, but the cluster itself is not actionable.
RVMD drugs
RVMD drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Aug 26 $215.44entry
- T+1 · 3mo ago +2.65%α +2.00% · $221.15
- T+5 · 3mo ago −2.88%α −2.76% · $209.23
- T+20 · 8w ago −7.23%α −7.38% · $199.86
- T+57 · todayOpen
- T+60 · in 2d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two insiders at Revolution Medicines, General Counsel Jeff Cislini and Director Mark Goldsmith, sold a combined ~$22.5M in open-market sales on August 21, 2026, following option exercises. The total open-market sales of ~$22.5M represent approximately 0.05% of RVMD's $45.3B market cap, which is below the 0.1% threshold for materiality. While the cluster timing is notable (same-day sales by both insiders), the dollar amount relative to market cap is trivial, and the sales are clearly tied to option exercises (liquidity-driven, not informational).
Key Financial Metrics
Key Facts
- Two insiders sold shares on August 21, 2026: General Counsel Jeff Cislini and Director Mark Goldsmith
- Total open-market sales: ~$22.5M (Cislini: ~$11.9M, Goldsmith: ~$10.5M)
- All sales followed option exercises, Cislini exercised options at $0 and $18.56-$21.61 strike, Goldsmith exercised options at $0 strike
- Total sales represent ~0.05% of RVMD's $45.3B market cap, below the 0.1% materiality threshold
- No insider buying in the cluster, net direction is selling
- RVMD has 93% analyst bullish consensus (26 Buy/10 Strong Buy out of 28 analysts)
Financial Impact
Total open-market sales of ~$22.5M represent ~0.05% of market cap, trivial relative to company size
Risk Factors
- Insider sales could accelerate if the stock continues its strong run (up ~12%+ on average per prior reports)
- Option exercises increase share count modestly, though the dilution is immaterial at this scale
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-RVMD-1787728254135 |
Track record
44 reports on RVMD
7 of 10 bullish or bearish reports moved the stock their way by T+60. Best: +31.56% at T+60 after the Apr 21, 2026 report. 17 of 18 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 3/10 Entry $167.00 Now $166.87 −0.08% settles Feb 16
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $168.20 Now $166.87 −0.79% settles Feb 12
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $176.02 Now $166.87 −5.20% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $176.35 Now $166.87 −5.38% settles Feb 10
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
- Nov 4, 202612d ago 8-K Bullish 7/10 No price data
- Nov 4, 202612d ago Press Release Neutral 5/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $191.31 Now $166.87 −12.78% settles Jan 28
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $186.99 Now $166.87 −10.76% settles Jan 21
- Oct 21, 202626d ago Press Release Neutral 1/10 Entry $187.69 Now $166.87 −11.09% settles Jan 20
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers